Wild-type amyloidosis, also known as senile amyloidosis, is a condition characterized by the abnormal accumulation of amyloid proteins in various tissues of the body. Unlike other forms of amyloidosis, it primarily affects older adults and is considered a natural part of aging.

What Is Amyloidosis?

Amyloidosis is a group of diseases caused by the buildup of amyloid proteins—misfolded proteins that form insoluble fibrils. These fibrils deposit in organs and tissues, impairing their normal function. There are several types of amyloidosis, classified based on the type of amyloid protein involved.

What Is Wild-Type Amyloidosis?

Wild-type amyloidosis involves the deposition of transthyretin (TTR) amyloid proteins that are produced naturally by the body. It is called "wild-type" because it does not involve genetic mutations. Instead, it occurs due to age-related changes in protein stability, leading to amyloid buildup.

How Does It Differ from Other Types?

  • Genetic vs. Non-Genetic: Wild-type amyloidosis is not inherited, unlike hereditary forms caused by genetic mutations.
  • Age of Onset: It primarily affects older adults, usually over 70 years old, whereas other types can affect younger individuals.
  • Organ Involvement: Commonly impacts the heart, leading to restrictive cardiomyopathy, while other forms may affect kidneys, nerves, or other organs.
  • Treatment: Management focuses on symptom relief and slowing progression, with some cases benefiting from transthyretin stabilizers.

Symptoms and Diagnosis

Symptoms depend on the organs involved. For cardiac amyloidosis, symptoms may include shortness of breath, fatigue, and swelling. Diagnosis involves imaging tests, biopsies, and specialized blood tests to identify amyloid deposits and determine their type.

Conclusion

Wild-type amyloidosis is a progressive condition mainly affecting the elderly, characterized by the buildup of transthyretin amyloid proteins. Understanding its differences from other amyloidosis types helps in accurate diagnosis and management, improving patient outcomes.